This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jan 14;379(9811):96-8.

doi: 10.1016/S0140-6736(11)61580-8. Epub 2011 Nov 27.

Idrabiotaparinux treatment for venous thromboembolism

John W Eikelboom¹, Jeffrey I Weitz

Affiliations

PMID: 22127297
DOI: 10.1016/S0140-6736(11)61580-8

Comment

Idrabiotaparinux treatment for venous thromboembolism

John W Eikelboom et al. Lancet. 2012.

. 2012 Jan 14;379(9811):96-8.

doi: 10.1016/S0140-6736(11)61580-8. Epub 2011 Nov 27.

Authors

John W Eikelboom¹, Jeffrey I Weitz

Affiliation

¹ Department of Medicine, McMaster University, ON, Canada.

PMID: 22127297
DOI: 10.1016/S0140-6736(11)61580-8

No abstract available

PubMed Disclaimer

Comment on

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Büller HR, Gallus AS, Pillion G, Prins MH, Raskob GE; Cassiopea Investigators. Büller HR, et al. Lancet. 2012 Jan 14;379(9811):123-9. doi: 10.1016/S0140-6736(11)61505-5. Epub 2011 Nov 28. Lancet. 2012. PMID: 22130488 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information